Pro-Active Dasatinib Dose Reduction Based on Trough Levels May Minimise Toxicity and Preserve Efficacy - Interim Analysis of the ALLG CML 12 Direct StudyDavid T. Yeung,Andrew Grigg,Naranie Shanmuganathan,Ann Christine Solterbeck,Deborah L. White,Susan Branford,Nicholas Viiala,Philip Arthur Rowlings,Anthony K. Mills,Jake Shortt,Campbell Tiley,David M. Ross,David Kipp,Rosemary Anne Harrup,Ilona Cunningham,John Kwan,Richard Eek,Howard Mutsando, Ken-Soon Tan,Kate Burbury,Matthew P. F. Wright,Timothy P. HughesBLOOD（2019）引用 0|浏览164AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
